Recent Finacing
Recent Raise
Relypsa is a clinical-stage pharmaceutical company developing non-absorbed polymeric drugs, advancing patiromer (RLY5016), an oral high-capacity potassium binder, through pivotal trials for hyperkalemia in kidney and heart disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors